Jacopo Mariotti

2.0k total citations
56 papers, 1.2k citations indexed

About

Jacopo Mariotti is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Jacopo Mariotti has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 30 papers in Immunology and 26 papers in Oncology. Recurrent topics in Jacopo Mariotti's work include Hematopoietic Stem Cell Transplantation (38 papers), Immune Cell Function and Interaction (18 papers) and CAR-T cell therapy research (14 papers). Jacopo Mariotti is often cited by papers focused on Hematopoietic Stem Cell Transplantation (38 papers), Immune Cell Function and Interaction (18 papers) and CAR-T cell therapy research (14 papers). Jacopo Mariotti collaborates with scholars based in Italy, United States and France. Jacopo Mariotti's co-authors include Daniel H. Fowler, Jason Foley, Luca Castagna, Michael Eckhaus, Shoba Amarnath, Barbara Sarina, Stéfania Bramanti, John J. O’Shea, Yong Chan Kim and Paolo Corradini and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Immunity.

In The Last Decade

Jacopo Mariotti

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacopo Mariotti Italy	20	667	562	410	158	111	56	1.2k
Cornelis A.M. van Bergen Netherlands	20	949 1.4×	622 1.1×	480 1.2×	232 1.5×	92 0.8×	53	1.3k
Édouard Forcade France	18	372 0.6×	674 1.2×	441 1.1×	138 0.9×	85 0.8×	105	1.2k
Thai M. Cao United States	17	319 0.5×	379 0.7×	296 0.7×	164 1.0×	70 0.6×	48	866
Ram Malladi United Kingdom	20	442 0.7×	935 1.7×	366 0.9×	248 1.6×	79 0.7×	64	1.4k
Chiara Gentilini Germany	14	605 0.9×	252 0.4×	396 1.0×	177 1.1×	125 1.1×	24	932
F. García‐Sánchez Spain	17	420 0.6×	383 0.7×	218 0.5×	219 1.4×	72 0.6×	119	1000
Marilyn Thien Australia	7	856 1.3×	242 0.4×	153 0.4×	227 1.4×	86 0.8×	14	1.3k
Leo Luznik United States	22	910 1.4×	1.3k 2.3×	658 1.6×	237 1.5×	94 0.8×	60	1.8k
Axel Schulenburg Austria	18	216 0.3×	511 0.9×	337 0.8×	235 1.5×	92 0.8×	41	990
Janet Ayello United States	21	529 0.8×	341 0.6×	705 1.7×	368 2.3×	86 0.8×	117	1.3k

Countries citing papers authored by Jacopo Mariotti

Since Specialization

Citations

This map shows the geographic impact of Jacopo Mariotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacopo Mariotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacopo Mariotti more than expected).

Fields of papers citing papers by Jacopo Mariotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacopo Mariotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacopo Mariotti. The network helps show where Jacopo Mariotti may publish in the future.

Co-authorship network of co-authors of Jacopo Mariotti

This figure shows the co-authorship network connecting the top 25 collaborators of Jacopo Mariotti. A scholar is included among the top collaborators of Jacopo Mariotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacopo Mariotti. Jacopo Mariotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Philippis, Chiara De, Umberto Pensato, Daniela Taurino, et al.. (2024). Late-onset relapsing neurotoxicity after Brexucabtagene autoleucel associated with high chimeric antigen receptor T cells in cerebrospinal fluid. Cytotherapy. 27(1). 25–28. 1 indexed citations

Mariotti, Jacopo, Laura Giordano, Chiara De Philippis, et al.. (2024). Allogeneic transplantation after immunotherapy for relapsed/refractory non-Hodgkin lymphoma: a comparison with a historical cohort. Cytotherapy. 26(10). 1163–1169. 1 indexed citations

Philippis, Chiara De, Daniele Mannina, Laura Giordano, et al.. (2023). Impact of Preemptive Use of Tocilizumab on Chimeric Antigen Receptor T Cell Outcomes in Non-Hodgkin Lymphoma. Transplantation and Cellular Therapy. 29(7). 429.e1–429.e6. 12 indexed citations

Mariotti, Jacopo, Laura Giordano, Chiara De Philippis, et al.. (2022). EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide. Bone Marrow Transplantation. 58(3). 247–256. 12 indexed citations

Lia, Giuseppe, Clara Di Vito, Stefania Bruno, et al.. (2022). Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide. Frontiers in Immunology. 12. 816231–816231. 9 indexed citations

Abboud, Ramzi, Fei Wan, Jacopo Mariotti, et al.. (2021). Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis. Bone Marrow Transplantation. 56(11). 2763–2770. 25 indexed citations

Castagna, Luca, Inna Timofeeva, Stéfania Bramanti, et al.. (2021). Feasibility and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological Malignancies. Transplantation and Cellular Therapy. 27(6). 478.e1–478.e5. 18 indexed citations

Mariotti, Jacopo, Olaf Penack, & Luca Castagna. (2020). Acute Graft-versus-Host-Disease Other Than Typical Targets: Between Myths and Facts. Transplantation and Cellular Therapy. 27(2). 115–124. 14 indexed citations

Castagna, Luca, Thomas Pagliardini, Stéfania Bramanti, et al.. (2020). Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome. Bone Marrow Transplantation. 56(4). 883–889. 6 indexed citations

10.

Mariotti, Jacopo, Daniela Taurino, Stéfania Bramanti, et al.. (2019). Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide. Cancer Medicine. 9(1). 52–61. 12 indexed citations

11.

Bramanti, Stéfania, Valeria Calafiore, Elena Vittoria Longhi, et al.. (2019). Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes. Biology of Blood and Marrow Transplantation. 25(7). 1395–1406. 37 indexed citations

12.

Mariotti, Jacopo, Raynier Devillier, Stéfania Bramanti, et al.. (2019). Peripheral Blood Stem Cells versus Bone Marrow for T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 25(9). 1810–1817. 13 indexed citations

13.

Mussetti, Alberto, Chiara De Philippis, Cristiana Carniti, et al.. (2018). CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide. Bone Marrow Transplantation. 53(12). 1522–1531. 18 indexed citations

14.

Mineri, Rossana, Jacopo Mariotti, Barbara Sarina, et al.. (2018). Genomic integration of HHV-6 mimicking viral reactivation after autologous stem cell transplantation. Mediterranean Journal of Hematology and Infectious Diseases. 10(1). e2018013–e2018013. 1 indexed citations

15.

Mussetti, Alberto, Chiara De Philippis, Cristiana Carniti, et al.. (2017). CD3 Lymphocyte Graft Content and Not Hematopoietic Stem Cell Source Is Associated to Higher Chronic GVHD after Haploidentical Transplantation with Post-Transplant Cyclophosphamide. Blood. 130. 4587. 1 indexed citations

16.

Carniti, Cristiana, Silvia Gimondi, Antonio Vendramin, et al.. (2015). Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects. Clinical Cancer Research. 21(16). 3740–3749. 95 indexed citations

17.

Mariotti, Jacopo, Francesco Maura, Francesco Spina, et al.. (2014). Impact of Cytomegalovirus Replication and Cytomegalovirus Serostatus on the Outcome of Patients with B Cell Lymphoma after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(6). 885–890. 32 indexed citations

18.

Amarnath, Shoba, Francis A. Flomerfelt, Carliann M. Costanzo, et al.. (2010). Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD. Autophagy. 6(4). 523–541. 27 indexed citations

19.

Amarnath, Shoba, Carliann M. Costanzo, Jacopo Mariotti, et al.. (2010). Regulatory T Cells and Human Myeloid Dendritic Cells Promote Tolerance via Programmed Death Ligand-1. PLoS Biology. 8(2). e1000302–e1000302. 79 indexed citations

20.

Jung, Unsu, Jason Foley, Andreas Erdmann, et al.. (2006). Ex Vivo Rapamycin Generates Th1/Tc1 or Th2/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-transplant Rapamycin Therapy. Biology of Blood and Marrow Transplantation. 12(9). 905–918. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact